This vial contains three synthetic peptides co-lyophilized in fixed amounts: GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex) 50mg, BPC-157 (15-amino-acid synthetic peptide) 10mg, and TB-500 (thymosin β-4–related synthetic peptide) 10mg.
The combination is supplied for in vitro studies comparing the individual components with the mixture, such as extracellular-matrix protein binding, actin-binding, and endothelial tube-formation assays in cell lines.
Specifications
- Components: GHK-Cu 50mg · BPC-157 10mg · TB-500 10mg (70mg per vial, labeled)
- Form: lyophilized powder
- Purity: >99.50% (HPLC-UV/VIS), endotoxin pass · lot GLOW-PR-6825 · Vanguard Laboratory report V260831-33, 9/11/2026
- Purity: 99.94% (HPLC), identity confirmed, endotoxin 0.082 EU/mL · ILS Laboratories COA-2026-ORRNDH, analyzed 06/29/2026
- All reports: see COAs tab
Storage: Store lyophilized material at −20 °C, protected from light and moisture.
For in vitro laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement. Not for diagnostic or therapeutic use.
For in vitro laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement. Not for diagnostic or therapeutic use.
